It plays a vital role in detoxification, immune function and helps combat free radicals, which can damage cells and contribute to aging
Additionally, both GLP-1 and GIP play a role in cardiovascular disease, as agonists of GLP-1 have been shown to reduce platelet activation, thus supporting a protective effect of GLP-1 against microvascular thrombosis [24]
The drug was removed from the Drug Shortage List in February 2025 after being added to the list in August 2022
In response, Stoops NYC, a dispensary in New Yorks Flatiron district, increasingly recommends lower-dose edibles, vapes or tinctures to customers on GLP-1 medications
The prescribed medication is not in the formulary
Phentermine and topiramate extended release (Qsymia): first global approval